Click for best price
Diabetes Management Market Size, Share 2024
| Market size in 2023 |
US$ 5063.9 million
|
Forecast Market size by 2030 |
US$ 12880 million
|
| Growth Rate |
CAGR of 14.2% |
Number of Pages |
104 Pages |
This research report provides a comprehensive analysis of the Diabetes Management market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Diabetes Management market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Diabetes Management, challenges faced by the industry, and potential opportunities for market players.
The global Diabetes Management market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Diabetes Management market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Diabetes Management market. Additionally, the growing consumer demand present avenues for market expansion.
The global Diabetes Management market was valued at US$ 5063.9 million in 2023 and is projected to reach US$ 12880 million by 2030, at a CAGR of 14.2% during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents? wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Key Features:
The research report on the Diabetes Management market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Diabetes Management market.
Market Overview: The report provides a comprehensive overview of the Diabetes Management market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monitoring Devices, Diagnostic Devices), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Diabetes Management market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Diabetes Management market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Diabetes Management market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Diabetes Management market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Diabetes Management market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Diabetes Management market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Diabetes Management, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Diabetes Management market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Diabetes Management market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
Market segment by Application
Hospital
Clinic
Home Care
Global Diabetes Management Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Ascensia Diabetes Care
Abbott Laboratories
Medtronic
Roche
Dexcom
Insulet Corporation
Tandem Diabetes Care
LifeScan
AgaMatrix
Animas
ARKRAY
BD
Beta Bionics.
Eli Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Management, market overview.
Chapter 2: Global Diabetes Management market size in revenue.
Chapter 3: Detailed analysis of Diabetes Management company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Diabetes Management Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 5063.9 million
|
| Forecast Market size by 2030 |
US$ 12880 million
|
| Growth Rate |
CAGR of 14.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
104 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetes Management Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Management Overall Market Size
2.1 Global Diabetes Management Market Size: 2023 VS 2030
2.2 Global Diabetes Management Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Management Players in Global Market
3.2 Top Global Diabetes Management Companies Ranked by Revenue
3.3 Global Diabetes Management Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Management Companies in Global Market, by Revenue in 2023
3.5 Global Companies Diabetes Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Management Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Management Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Management Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Management Market Size Markets, 2023 & 2030
4.1.2 Monitoring Devices
4.1.3 Diagnostic Devices
4.1.4 Insulin Delivery Devices
4.1.5 Other Devices
4.2 By Type - Global Diabetes Management Revenue & Forecasts
4.2.1 By Type - Global Diabetes Management Revenue, 2019-2024
4.2.2 By Type - Global Diabetes Management Revenue, 2025-2030
4.2.3 By Type - Global Diabetes Management Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Management Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Home Care
5.2 By Application - Global Diabetes Management Revenue & Forecasts
5.2.1 By Application - Global Diabetes Management Revenue, 2019-2024
5.2.2 By Application - Global Diabetes Management Revenue, 2025-2030
5.2.3 By Application - Global Diabetes Management Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Diabetes Management Market Size, 2023 & 2030
6.2 By Region - Global Diabetes Management Revenue & Forecasts
6.2.1 By Region - Global Diabetes Management Revenue, 2019-2024
6.2.2 By Region - Global Diabetes Management Revenue, 2025-2030
6.2.3 By Region - Global Diabetes Management Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Diabetes Management Revenue, 2019-2030
6.3.2 US Diabetes Management Market Size, 2019-2030
6.3.3 Canada Diabetes Management Market Size, 2019-2030
6.3.4 Mexico Diabetes Management Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Diabetes Management Revenue, 2019-2030
6.4.2 Germany Diabetes Management Market Size, 2019-2030
6.4.3 France Diabetes Management Market Size, 2019-2030
6.4.4 U.K. Diabetes Management Market Size, 2019-2030
6.4.5 Italy Diabetes Management Market Size, 2019-2030
6.4.6 Russia Diabetes Management Market Size, 2019-2030
6.4.7 Nordic Countries Diabetes Management Market Size, 2019-2030
6.4.8 Benelux Diabetes Management Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Diabetes Management Revenue, 2019-2030
6.5.2 China Diabetes Management Market Size, 2019-2030
6.5.3 Japan Diabetes Management Market Size, 2019-2030
6.5.4 South Korea Diabetes Management Market Size, 2019-2030
6.5.5 Southeast Asia Diabetes Management Market Size, 2019-2030
6.5.6 India Diabetes Management Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Diabetes Management Revenue, 2019-2030
6.6.2 Brazil Diabetes Management Market Size, 2019-2030
6.6.3 Argentina Diabetes Management Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Management Revenue, 2019-2030
6.7.2 Turkey Diabetes Management Market Size, 2019-2030
6.7.3 Israel Diabetes Management Market Size, 2019-2030
6.7.4 Saudi Arabia Diabetes Management Market Size, 2019-2030
6.7.5 UAE Diabetes Management Market Size, 2019-2030
7 Diabetes Management Companies Profiles
7.1 Ascensia Diabetes Care
7.1.1 Ascensia Diabetes Care Company Summary
7.1.2 Ascensia Diabetes Care Business Overview
7.1.3 Ascensia Diabetes Care Diabetes Management Major Product Offerings
7.1.4 Ascensia Diabetes Care Diabetes Management Revenue in Global Market (2019-2024)
7.1.5 Ascensia Diabetes Care Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Diabetes Management Major Product Offerings
7.2.4 Abbott Laboratories Diabetes Management Revenue in Global Market (2019-2024)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Medtronic
7.3.1 Medtronic Company Summary
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Diabetes Management Major Product Offerings
7.3.4 Medtronic Diabetes Management Revenue in Global Market (2019-2024)
7.3.5 Medtronic Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Diabetes Management Major Product Offerings
7.4.4 Roche Diabetes Management Revenue in Global Market (2019-2024)
7.4.5 Roche Key News & Latest Developments
7.5 Dexcom
7.5.1 Dexcom Company Summary
7.5.2 Dexcom Business Overview
7.5.3 Dexcom Diabetes Management Major Product Offerings
7.5.4 Dexcom Diabetes Management Revenue in Global Market (2019-2024)
7.5.5 Dexcom Key News & Latest Developments
7.6 Insulet Corporation
7.6.1 Insulet Corporation Company Summary
7.6.2 Insulet Corporation Business Overview
7.6.3 Insulet Corporation Diabetes Management Major Product Offerings
7.6.4 Insulet Corporation Diabetes Management Revenue in Global Market (2019-2024)
7.6.5 Insulet Corporation Key News & Latest Developments
7.7 Tandem Diabetes Care
7.7.1 Tandem Diabetes Care Company Summary
7.7.2 Tandem Diabetes Care Business Overview
7.7.3 Tandem Diabetes Care Diabetes Management Major Product Offerings
7.7.4 Tandem Diabetes Care Diabetes Management Revenue in Global Market (2019-2024)
7.7.5 Tandem Diabetes Care Key News & Latest Developments
7.8 LifeScan
7.8.1 LifeScan Company Summary
7.8.2 LifeScan Business Overview
7.8.3 LifeScan Diabetes Management Major Product Offerings
7.8.4 LifeScan Diabetes Management Revenue in Global Market (2019-2024)
7.8.5 LifeScan Key News & Latest Developments
7.9 AgaMatrix
7.9.1 AgaMatrix Company Summary
7.9.2 AgaMatrix Business Overview
7.9.3 AgaMatrix Diabetes Management Major Product Offerings
7.9.4 AgaMatrix Diabetes Management Revenue in Global Market (2019-2024)
7.9.5 AgaMatrix Key News & Latest Developments
7.10 Animas
7.10.1 Animas Company Summary
7.10.2 Animas Business Overview
7.10.3 Animas Diabetes Management Major Product Offerings
7.10.4 Animas Diabetes Management Revenue in Global Market (2019-2024)
7.10.5 Animas Key News & Latest Developments
7.11 ARKRAY
7.11.1 ARKRAY Company Summary
7.11.2 ARKRAY Business Overview
7.11.3 ARKRAY Diabetes Management Major Product Offerings
7.11.4 ARKRAY Diabetes Management Revenue in Global Market (2019-2024)
7.11.5 ARKRAY Key News & Latest Developments
7.12 BD
7.12.1 BD Company Summary
7.12.2 BD Business Overview
7.12.3 BD Diabetes Management Major Product Offerings
7.12.4 BD Diabetes Management Revenue in Global Market (2019-2024)
7.12.5 BD Key News & Latest Developments
7.13 Beta Bionics.
7.13.1 Beta Bionics. Company Summary
7.13.2 Beta Bionics. Business Overview
7.13.3 Beta Bionics. Diabetes Management Major Product Offerings
7.13.4 Beta Bionics. Diabetes Management Revenue in Global Market (2019-2024)
7.13.5 Beta Bionics. Key News & Latest Developments
7.14 Eli Lilly
7.14.1 Eli Lilly Company Summary
7.14.2 Eli Lilly Business Overview
7.14.3 Eli Lilly Diabetes Management Major Product Offerings
7.14.4 Eli Lilly Diabetes Management Revenue in Global Market (2019-2024)
7.14.5 Eli Lilly Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetes Management Market Opportunities & Trends in Global Market
Table 2. Diabetes Management Market Drivers in Global Market
Table 3. Diabetes Management Market Restraints in Global Market
Table 4. Key Players of Diabetes Management in Global Market
Table 5. Top Diabetes Management Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Diabetes Management Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Diabetes Management Revenue Share by Companies, 2019-2024
Table 8. Global Companies Diabetes Management Product Type
Table 9. List of Global Tier 1 Diabetes Management Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Management Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Diabetes Management Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Diabetes Management Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Diabetes Management Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Diabetes Management Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Diabetes Management Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Diabetes Management Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Diabetes Management Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Diabetes Management Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Diabetes Management Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Diabetes Management Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Diabetes Management Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Diabetes Management Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Diabetes Management Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Diabetes Management Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Diabetes Management Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Diabetes Management Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Diabetes Management Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Diabetes Management Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Diabetes Management Revenue, (US$, Mn), 2025-2030
Table 30. Ascensia Diabetes Care Company Summary
Table 31. Ascensia Diabetes Care Diabetes Management Product Offerings
Table 32. Ascensia Diabetes Care Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 33. Ascensia Diabetes Care Key News & Latest Developments
Table 34. Abbott Laboratories Company Summary
Table 35. Abbott Laboratories Diabetes Management Product Offerings
Table 36. Abbott Laboratories Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 37. Abbott Laboratories Key News & Latest Developments
Table 38. Medtronic Company Summary
Table 39. Medtronic Diabetes Management Product Offerings
Table 40. Medtronic Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 41. Medtronic Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Diabetes Management Product Offerings
Table 44. Roche Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 45. Roche Key News & Latest Developments
Table 46. Dexcom Company Summary
Table 47. Dexcom Diabetes Management Product Offerings
Table 48. Dexcom Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 49. Dexcom Key News & Latest Developments
Table 50. Insulet Corporation Company Summary
Table 51. Insulet Corporation Diabetes Management Product Offerings
Table 52. Insulet Corporation Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 53. Insulet Corporation Key News & Latest Developments
Table 54. Tandem Diabetes Care Company Summary
Table 55. Tandem Diabetes Care Diabetes Management Product Offerings
Table 56. Tandem Diabetes Care Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 57. Tandem Diabetes Care Key News & Latest Developments
Table 58. LifeScan Company Summary
Table 59. LifeScan Diabetes Management Product Offerings
Table 60. LifeScan Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 61. LifeScan Key News & Latest Developments
Table 62. AgaMatrix Company Summary
Table 63. AgaMatrix Diabetes Management Product Offerings
Table 64. AgaMatrix Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 65. AgaMatrix Key News & Latest Developments
Table 66. Animas Company Summary
Table 67. Animas Diabetes Management Product Offerings
Table 68. Animas Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 69. Animas Key News & Latest Developments
Table 70. ARKRAY Company Summary
Table 71. ARKRAY Diabetes Management Product Offerings
Table 72. ARKRAY Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 73. ARKRAY Key News & Latest Developments
Table 74. BD Company Summary
Table 75. BD Diabetes Management Product Offerings
Table 76. BD Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 77. BD Key News & Latest Developments
Table 78. Beta Bionics. Company Summary
Table 79. Beta Bionics. Diabetes Management Product Offerings
Table 80. Beta Bionics. Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 81. Beta Bionics. Key News & Latest Developments
Table 82. Eli Lilly Company Summary
Table 83. Eli Lilly Diabetes Management Product Offerings
Table 84. Eli Lilly Diabetes Management Revenue (US$, Mn) & (2019-2024)
Table 85. Eli Lilly Key News & Latest Developments
List of Figures
Figure 1. Diabetes Management Segment by Type in 2023
Figure 2. Diabetes Management Segment by Application in 2023
Figure 3. Global Diabetes Management Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Diabetes Management Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Diabetes Management Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Management Revenue in 2023
Figure 8. By Type - Global Diabetes Management Revenue Market Share, 2019-2030
Figure 9. By Application - Global Diabetes Management Revenue Market Share, 2019-2030
Figure 10. By Type - Global Diabetes Management Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Diabetes Management Revenue Market Share, 2019-2030
Figure 12. By Application - Global Diabetes Management Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Diabetes Management Revenue Market Share, 2019-2030
Figure 14. By Region - Global Diabetes Management Revenue Market Share, 2019-2030
Figure 15. By Country - North America Diabetes Management Revenue Market Share, 2019-2030
Figure 16. US Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Diabetes Management Revenue Market Share, 2019-2030
Figure 20. Germany Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 21. France Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Diabetes Management Revenue Market Share, 2019-2030
Figure 28. China Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 32. India Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Diabetes Management Revenue Market Share, 2019-2030
Figure 34. Brazil Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Diabetes Management Revenue Market Share, 2019-2030
Figure 37. Turkey Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Diabetes Management Revenue, (US$, Mn), 2019-2030
Figure 41. Ascensia Diabetes Care Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Abbott Laboratories Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Medtronic Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Roche Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Dexcom Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Insulet Corporation Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Tandem Diabetes Care Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. LifeScan Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. AgaMatrix Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Animas Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. ARKRAY Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. BD Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Beta Bionics. Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Eli Lilly Diabetes Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
